Esperion Therapeutics, Inc. Share Price Today: Live Updates & Key Insights
Esperion Therapeutics, Inc. share price today is $2.57, up -1.92%. The stock opened at $2.6 against the previous close of $2.6, with an intraday high of $2.6 and low of $2.51.
Esperion Therapeutics, Inc. Share Price Chart
Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc. Share Price Performance
Esperion Therapeutics, Inc. Institutional Holdings
Esperion Therapeutics, Inc. Market Status
Esperion Therapeutics, Inc. Fundamentals
Market Cap 654.87 M
PB Ratio 98.4236
PE Ratio 0.0
Enterprise Value 739.25 M
Total Assets 465.89 M
Volume 5717057
Esperion Therapeutics, Inc. Company Financials
About Esperion Therapeutics, Inc. & investment objective
Company Information Esperion Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States. The company's marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia cardiovascular disease who require additional lowering of LDL-C. Its products also include NILEMDO, an ATP Citrate Lyase (ACL) inhibitor that lowers LDL-C and cardiovascular risk by reducing cholesterol biosynthesis and up-regulating the LDL receptors; and NUSTENDI, a bempedoic acid and ezetimibe tablet to treat elevated LDL-C. It has license and collaboration agreements with Daiichi Sankyo Co. Ltd to; Otsuka Pharmaceutical Co., Ltd; and Daiichi Sankyo Europe GmbH. Esperion Therapeutics, Inc. was formerly known as HDL Therapeutics, Inc. and changed its name to Esperion Therapeutics, Inc. in May 2008. The company was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.
Organisation Drug Manufacturers - Specialty & Generic
Employees 294
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Sheldon L. Koenig M.B.A.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Esperion Therapeutics, Inc. FAQs
What is the share price of Esperion Therapeutics, Inc. today?
The current share price of Esperion Therapeutics, Inc. is $2.57.
Can I buy Esperion Therapeutics, Inc. shares in India?
Yes, Indian investors can buy Esperion Therapeutics, Inc. shares by opening an international trading and demat account with Motilal Oswal.
How to buy Esperion Therapeutics, Inc. shares in India?
You can easily invest in Esperion Therapeutics, Inc. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Esperion Therapeutics, Inc. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Esperion Therapeutics, Inc..
Can I buy fractional shares of Esperion Therapeutics, Inc.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Esperion Therapeutics, Inc.?
Esperion Therapeutics, Inc. has a market cap of $654.87 M.
In which sector does Esperion Therapeutics, Inc. belong?
Esperion Therapeutics, Inc. operates in the Drug Manufacturers - Specialty & Generic sector.
What documents are required to invest in Esperion Therapeutics, Inc. stocks?
To invest, you typically need:
What is the PE and PB ratio of Esperion Therapeutics, Inc.?
The PE ratio of Esperion Therapeutics, Inc. is N/A and the PB ratio is 98.42.